September 30, 2014 | Shrija Agrawal
Launched in April this year, Religare sponsored fund currently has about $50 million in assets under management.
September 26, 2014 | Shruti Ambavat
Other investors in the firm include GDF International, T Rowe Price International, Government Pension Fund Global and Fidelity Investment Trust.
September 19, 2014 | Jasleen Kaur Batra
NephroLife, Sparsh Nephrocare and Deep Chand Dialysis are other peers that have attracted PE funding.
September 18, 2014 | Shruti Ambavat
Deal values Syngene at a premium to the recent transaction where Biocon bought back GE Capital's stake.
September 18, 2014 | Swet Sarika
The developer has attracted capital from Avenue Venture, JLL Segregated Funds Group, Amplus Capital in the past.
September 17, 2014 | Nikita Peer
The venture is part owned by public listed geospatial solutions firm Genesys International.